Curtis L. Cetrulo
Founder at Auxocell Laboratories, Inc.
Curtis L. Cetrulo active positions
| Companies | Position | Start | End |
|---|---|---|---|
OptMed, Inc.
 OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Director/Board Member | 30/04/2022 | - |
| Independent Dir/Board Member | 30/04/2022 | - | |
| Harvard Medical School | Corporate Officer/Principal | 31/12/2008 | - |
Auxocell Laboratories, Inc.
 Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | Founder | 31/12/2007 | - |
| Corporate Officer/Principal | 31/12/2007 | - |
Career history of Curtis L. Cetrulo
Training of Curtis L. Cetrulo
| Tufts University School of Medicine | Doctorate Degree |
Statistics
International
| United States | 5 |
Operational
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
OptMed, Inc.
OptMed, Inc. Medical SpecialtiesHealth Technology OptMed, Inc. is a clinical-stage medical device company, which engages in the development and commercialization of surgical adhesives for the treatment of patients with external and internal wounds. The firm offers products under the brands of BondEase Topical Skin Adhesive and TearRepair Liquid Skin Protectant. Its proprietary technology platform is based on a chemistry called methylidene malonate (MM212), a biocompatible polymer originally designed for drug delivery which has been tested for biocompatibility and adhesive properties in topical and internal applications. The company was founded by Alain Klapholz in 2007 and is headquartered in New York, NY. | Health Technology |
Auxocell Laboratories, Inc.
Auxocell Laboratories, Inc. Medical SpecialtiesHealth Technology Part of BioStem Technologies, Inc., Auxocell Laboratories, Inc. is a company that manufactures solid tissue processing equipment. The company is based in Cambridge, MA. The company was founded by Kyle J. Cetrulo, Curtis L. Cetrulo, Barrett W. Bready, Rouzbeh R. Taghizadeh. Kyle J. Cetrulo has been the CEO since incorporation. Auxocell Laboratories was acquired by BioStem Technologies, Inc. | Health Technology |
- Stock Market
- Insiders
- Curtis L. Cetrulo
- Experience